← Evidence map

ArticleImmunity, inflammation and disease2022

Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft-versus-host disease by inhibiting T-cell migration to the gastrointestinal tract.

Yukie Tsubokura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36039651